Effect of QUiPP prediction algorithm on treatment decisions in women with a previous preterm birth: a prospective cohort study.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
12 2019
Historique:
accepted: 16 07 2019
pubmed: 25 7 2019
medline: 19 11 2019
entrez: 25 7 2019
Statut: ppublish

Résumé

The QUiPP algorithm combines cervical length, quantitative fetal fibronectin (qfFN) and medical history to quantify risk of preterm birth. We assessed the utility of QUiPP to inform preterm birth prevention treatment decisions. A prospective cohort study with a subsequent impact assessment using the QUiPP risk of birth before 34 weeks' gestation. A UK tertiary referral hospital. In all, 119 women with previous spontaneous preterm birth (sPTB) or preterm premature rupture of membranes (PPROM) before 34 weeks' gestation. Cervical length and qfFN were measured at 19 Predictive statistics of QUiPP algorithm using 10% risk of sPTB before 34 Fifteen of 119 women (13%) had PPROM or sPTB before 34 weeks. Of these, 53% (8/15) had QUiPP risk of sPTB before 34 Use of the QUiPP algorithm in this population may lead to substantial increase in interventions without evidence that currently available treatment options are beneficial for this particular group. Independent study finds that the QUiPP algorithm could lead to substantial increases in treatment without evidence of benefit.

Identifiants

pubmed: 31339631
doi: 10.1111/1471-0528.15886
doi:

Substances chimiques

Biomarkers 0
Fibronectins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1569-1575

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2019 Royal College of Obstetricians and Gynaecologists.

Références

Lim K, Butt K, No CJ. No. 257-ultrasonographic cervical length assessment in predicting preterm birth in singleton pregnancies. J Obstet Gynaecol Can 2018;40:e151-64.
National Institute for Clinical Excellence. Preterm labour and birth, full guideline [Internet]. 2015 [www.nice.org.uk/guidance/ng25]. Accessed 2 December 2018.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Measurement of cervical length for prediction of preterm birth [Internet]. 2017 [www.ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27sHealth/Statement and guidelines/Clinical-Obstetrics/Measurement-of-cervical-length-for-prediction-of-preterm-birth(C-Obs-27)-Review-July-2017.pdf?ext=.pdf]. Accessed 2 December 2018.
Care AG, Sharp AN, Lane S, Roberts D, Watkins L, Alfirevic Z. Predicting preterm birth in women with previous preterm birth and cervical length ≥ 25 mm. Ultrasound Obstet Gynecol 2014;43:681-6.
Women's Health Academic Division KCL. The QUiPP app website [Internet] [https://quipp.org]. Accessed 22 November 2018.
Kings Health Partners. About QUiPP [Internet]. 2018 [https://quipp.org/about.html]. Accessed 26 October 2018.
Care A, Ingleby L, Alfirevic Z, Sharp A. The influence of the introduction of national guidelines on preterm birth prevention practice: UK experience. BJOG 2019;126:763-9.
Salomon LJ, Diaz-Garcia C, Bernard JP, Ville Y. Reference range for cervical length throughout pregnancy: non-parametric LMS-based model applied to a large sample. Ultrasound Obstet Gynecol 2009;33:459-64.
Hezelgrave NL, Kuhrt K, Cottam K, Seed PT, Tribe RM, Shennan AH. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth. Eur J Obstet Gynecol Reprod Biol 2017;208:103-8.
McLaren JS, Hezelgrave NL, Ayubi H, Seed PT, Shennan AH. Prediction of spontaneous preterm birth using quantitative fetal fibronectin after recent sexual intercourse. Am J Obstet Gynecol 2015;212:89.e1-5.
Kuhrt K, Hezelgrave N, Foster C, Seed PT, Shennan AH. Development and validation of a tool incorporating quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic women. Ultrasound Obstet Gynecol 2016;47:104-9.
Van't Hooft J, Duffy JMN, Daly M, Williamson PR, Meher S, Thom E, et al. A core outcome set for evaluation of interventions to prevent preterm birth. Obstet Gynecol 2016;127:49-58.
Stock SJ, Ismail KMK. Which intervention reduces the risk of preterm birth in women with risk factors? BMJ 2016;355:i5206.
The American College of Obstetricians and Gynaecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012;120:964-73.
Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013;(7):CD004947.
Norman JE, Marlow N, Messow C-M, Shennan A, Bennett PR, Thornton S, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet 2016;387:2106-16.
Stewart LA, Simmonds M, Duley L, Dietz KC, Harden M, Hodkinson A, et al. Evaluating progestogens for prevention of preterm birth international collaborative (EPPPIC) individual participant data (IPD) meta-analysis: protocol. Syst Rev 2017;6:235.

Auteurs

L Goodfellow (L)

University of Liverpool and Liverpool Women's Hospital, Liverpool, UK.
Liverpool Health Partners, Liverpool, UK.

A Care (A)

University of Liverpool and Liverpool Women's Hospital, Liverpool, UK.
Liverpool Health Partners, Liverpool, UK.

A Sharp (A)

University of Liverpool and Liverpool Women's Hospital, Liverpool, UK.
Liverpool Health Partners, Liverpool, UK.

J Ivandic (J)

University of Liverpool and Liverpool Women's Hospital, Liverpool, UK.
Liverpool Health Partners, Liverpool, UK.

B Poljak (B)

Liverpool Health Partners, Liverpool, UK.
Liverpool Women's Hospital, Liverpool, UK.

D Roberts (D)

Liverpool Health Partners, Liverpool, UK.
Liverpool Women's Hospital, Liverpool, UK.

Z Alfirevic (Z)

University of Liverpool and Liverpool Women's Hospital, Liverpool, UK.
Liverpool Health Partners, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH